Key result
Transcatheter leadless pacemakers present unique technical challenges in children due to small chamber and vein size.
Why the study?
The safety and efficacy of leadless pacemakers in pediatric patients are less well described compared to adults, with unique technical challenges in implantation.
Demands specialized expertise and vein assessment in pediatrics; leaves open long-term safety data in growing patients.
Transcatheter leadless pacemakers (LP) eliminate pocket and lead-related complications associated with traditional transvenous pacing systems. The safety and efficacy of LP are well described in the adult population 1,2. Recently, pediatric studies have also found its use favorable in select patient populations 3. The LP is particularly useful in pediatric patients with transient or paroxysmal atrioventricular (AV) block and those with prolonged pauses leading to symptoms. Technical challenges unique to pediatric implantation include smaller patient size, smaller cardiac chamber size, proximity to the tricuspid (TV) and pulmonary valve (PV), and the need for adequate vein size of at least 9mm to safely accept the delivery system 4.
No takes yet. Share an insight, caveat, or question.
Gutierrez et al. (2026) studied Pediatric patients requiring pacemakers. Transesophageal echocardiography during leadless pacemaker implantation was evaluated. Transcatheter leadless pacemakers in pediatric patients present unique technical challenges including smaller patient size, smaller cardiac chamber size, and the need for adequate vein size.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: